> top > docs > PMC:7417114 > spans > 80049-80889 > annotations

PMC:7417114 / 80049-80889 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T400 196-200 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T132 196-200 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T723 51-59 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T724 100-131 Disease denotes Waldenstrom’s macroglobulinemia http://purl.obolibrary.org/obo/MONDO_0007926
T725 114-131 Disease denotes macroglobulinemia http://purl.obolibrary.org/obo/MONDO_0005190
T726 219-227 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T909 49-50 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T910 78-79 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T911 196-200 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T912 196-200 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T913 492-493 http://purl.obolibrary.org/obo/CLO_0001020 denotes a

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T2881 154-163 Chemical denotes ibrutinib http://purl.obolibrary.org/obo/CHEBI_76612
T6567 382-391 Chemical denotes ibrutinib http://purl.obolibrary.org/obo/CHEBI_76612
T61850 508-517 Chemical denotes ibrutinib http://purl.obolibrary.org/obo/CHEBI_76612
T32325 598-607 Chemical denotes ibrutinib http://purl.obolibrary.org/obo/CHEBI_76612
T8528 637-655 Chemical denotes hydroxychloroquine http://purl.obolibrary.org/obo/CHEBI_5801
T37513 657-669 Chemical denotes azithromycin http://purl.obolibrary.org/obo/CHEBI_2955
T30666 674-685 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360
T20833 761-770 Chemical denotes ibrutinib http://purl.obolibrary.org/obo/CHEBI_76612

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
2475 132-140 Species denotes patients Tax:9606
2476 228-236 Species denotes patients Tax:9606
2477 353-361 Species denotes patients Tax:9606
2478 481-488 Species denotes patient Tax:9606
2479 717-724 Species denotes patient Tax:9606
2480 154-163 Chemical denotes ibrutinib MESH:C551803
2481 382-391 Chemical denotes ibrutinib MESH:C551803
2482 508-517 Chemical denotes ibrutinib MESH:C551803
2483 598-607 Chemical denotes ibrutinib MESH:C551803
2484 637-655 Chemical denotes hydroxychloroquine MESH:D006886
2485 657-669 Chemical denotes azithromycin MESH:D017963
2486 674-685 Chemical denotes tocilizumab MESH:C502936
2487 761-770 Chemical denotes ibrutinib MESH:C551803
2488 51-59 Disease denotes COVID-19 MESH:C000657245
2489 114-131 Disease denotes macroglobulinemia MESH:D008258
2490 196-207 Disease denotes lung damage MESH:D008171
2491 211-227 Disease denotes hypoxic COVID-19 MESH:C000657245
2492 338-343 Disease denotes COVID MESH:C000657245
2493 534-541 Disease denotes dyspnea MESH:D004417
2494 546-553 Disease denotes hypoxia MESH:D000860
2495 704-711 Disease denotes hypoxia MESH:D000860

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T240 100-131 Phenotype denotes Waldenstrom’s macroglobulinemia http://purl.obolibrary.org/obo/HP_0005508
T241 534-541 Phenotype denotes dyspnea http://purl.obolibrary.org/obo/HP_0002094
T242 546-553 Phenotype denotes hypoxia http://purl.obolibrary.org/obo/HP_0012418
T243 704-711 Phenotype denotes hypoxia http://purl.obolibrary.org/obo/HP_0012418

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T601 0-293 Sentence denotes Though not included on www.ClinicalTrials.gov as a COVID-19 trial, results of a clinical trial with Waldenstrom’s macroglobulinemia patients suggest that ibrutinib might confer protection against lung damage in hypoxic COVID-19 patients, and it may possibly improve respiratory function (165).
T602 294-472 Sentence denotes However, the study was small and involved 6 COVID-positive patients, 5 of whom received ibrutinib at 420 mg and presented with mild symptoms that did not require hospitalization.
T603 473-686 Sentence denotes The 6th patient on a lower dose of ibrutinib had progressive dyspnea and hypoxia and was placed on treatments in addition to ibrutinib at the lower dose, including hydroxychloroquine, azithromycin and tocilizumab.
T604 687-840 Sentence denotes Due to worsening hypoxia, the patient was eventually placed on the higher ibrutinib dose (420 mg) and this was followed by improvement of symptoms (165).